Naresh K. Nayyar
Conseiller Juridique Général chez TURG POIN
Postes actifs de Naresh K. Nayyar
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TURG POIN | Conseiller Juridique Général | 01/06/2018 | - |
Historique de carrière de Naresh K. Nayyar
Anciens postes connus de Naresh K. Nayyar
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/04/2016 | 01/05/2018 |
Formation de Naresh K. Nayyar
| University of Delhi | Doctorate Degree |
| University of Phoenix | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| Inde | 2 |
Opérationnelle
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Bourse
- Insiders
- Naresh K. Nayyar
- Expérience
